In a report released today, Tyler Radke from Citi maintained a Hold rating on Confluent (CFLT – Research Report), with a price target of ...

Evercore ISI analyst Chirag Ved maintained a Buy rating on Confluent (CFLT – Research Report) on February 7 and set a price target of $32.00.

Occupational therapists and physical therapists have different treatment goals for their patients, and they see different types of patients. Sometimes, these two types of healthcare professionals will ...

"This confluent support may serve as a floor for future price action, enabling consolidation within this current $101,000-$106,000 range," the analyst added. Another popular on-chain analyst and ...

with Neha Narkhede (Confluent), Anjali Sud (Tubi), Yamini Rangan (HubSpot), Leena Nair (Chanel), and Revathi Advaithi (Flex) collectively leading companies valued at $436 billion. The 2024 Hurun India ...

For the quarter, Confluent's overall revenue leaped 23% higher year over year to top $262 million, although its non-GAAP ...

Although the revenue and EPS for Confluent (CFLT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall ...

Confluent is a terrific "growth at a reasonable price" software stock that has only seen its share price rise ~20% over the past year, despite strong growth. Confluent, founded by creators of open ...

With more than 130 sites of care, IncreMedical Therapy Solutions has been a trusted partner to hospitals and health systems across the United States.Now as Confluent Health System Solutions, the ...

In the last three months, 11 analysts have published ratings on Confluent (NASDAQ:CFLT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...

As such, this is a guest post written by Peter Pugh-Jones, in his capacity as director of strategic accounts at Confluent. Understanding how the cadence and throughput of real-time data impacts ...